Wanqing Xie, Szuyao Hsu, Yuxuan Lin, Lv Xie, Xia Jin, Ziyu Zhu, Yunlu Guo, Caiyang Chen, Dan Huang, Johannes Boltze, Peiying Li
BACKGROUND: Patients with malignancies have an increased risk of suffering ischemic stroke via several mechanisms such as coagulation dysfunction and other malignancy-related effects as well as iatrogenic causes. Moreover, stroke can be the first sign of an occult malignancy, termed as malignancy-associated ischemic stroke (MAS). Therefore, timely diagnostic assessment and targeted management of this complex clinical situation are critical. FINDINGS: Patients with both stroke and malignancy have atypical ages, risk factors, and often exhibit malignancy-related symptoms and multiple lesions on neuroimaging...
March 2024: CNS Neuroscience & Therapeutics